Contraception

Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive

A biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced positive interim safety and efficacy results from its ongoing Phase 3 clinical trial evaluating the contraceptive effectiveness, safety and acceptability of Ovaprene®, the company’s investigational monthly, hormone-free intravaginal contraceptive. There currently are no FDA-approved, hormone-free, monthly intravaginal contraceptives.
Read More

After CDC cuts, doctors fear women will lose access to contraception research

To most people, the eight-person team was indistinguishable from the hundreds of other scientists and researchers cut in April during the mass firings at the Centers for Disease Control and Prevention. But for many clinicians who specialize in women’s health, losing the team responsible for the CDC’s contraception guidelines was a devastating blow to women’s health.
Read More

Right-to-contraception bills highlight key reproductive health care debate in this year’s elections

Contraception access is an issue resonating loudly within Virginia’s public and political spheres this year and last week, it manifested through state lawmakers contrasting Virginia’s twice-failed attempt to protect access to birth control medications against a similar measure that recently sailed through neighboring Tennessee’s legislature.  
Read More

Right-to-contraception bills highlight key reproductive health care debate in this year’s VA elections

Contraception access is an issue resonating loudly within Virginia’s public and political spheres this year and last week, it manifested through state lawmakers contrasting Virginia’s twice-failed attempt to protect access to birth control medications against a similar measure that recently sailed through neighboring Tennessee’s legislature.  
Read More

Oklahoma senators spurned fearmongering about women’s health. Will the House and governor step up?

A tip of the hat to Oklahoma’s state senators who managed to do some good governing that, for once, actually would help improve women’s health.  These brave lawmakers voted to allow women to access six months’s worth of birth control at a time. That would make life infinitely easier for tens of thousands of Oklahomans who rely on contraceptives to prevent unwanted pregnancies or to treat other medical problems such as acne, irregular periods or endometriosis.
Read More

Australian Government Subsidizes Key Medications To Boost Women’s Health

The Australian government is set to make significant changes to women’s health care by adding popular medications to the Pharmaceutical Benefits Scheme (PBS). Starting May 1, 2025, three major medications will be subsidized, providing financial relief to thousands of women facing high costs for contraceptive, endometriosis, and IVF treatments.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.